ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Purchase PDF (1851 K)

Article Toolbox
 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/0041-008X(90)90043-T    
How to Cite or Link Using DOI (Opens New Window)

Copyright © 1990 Published by Elsevier Inc.

Regular article

Triadimefon, a triazole fungicide, induces stereotyped behavior and alters monoamine metabolism in rats

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Q. David Walkera, Mark H. Lewisb, c, a, Kevin M. Croftone and Richard B. Mailmanb, c, d, a

a Curriculum in Toxicology, University of North Carolina, Chapel Hill, North Carolina 27599-7250, USA

b Biological Sciences Research Center, University of North Carolina, Chapel Hill, North Carolina 27599-7250, USA

c Department of Psychiatry, University of North Carolina, Chapel Hill, North Carolina 27599-7250, USA

d Department of Pharmacology, University of North Carolina, Chapel Hill, North Carolina 27599-7250, USA

e Neurotoxicology Division, U.S. Environmental Protection Agency, Research Triangle Park, North Carolina 27709, USA


Received 22 May 1989; 
accepted 2 November 1989. 
Available online 27 September 2004.

Abstract

Triadimefon, a triazole fungicide, has been observed to increase locomotion and induce stereotyped behavior in rodents. The present experiments designed to characterize the stereotyped behavior induced by triadimefon used a computer-supported observational method, and tested the hypothesis that these observed effects involved central dopaminergic systems. Adult male and female Sprague-Dawley rats were injected with triadimefon (0, 50, 100, and 200 mg/kg) in corn oil (2 ml/kg ip) 4 hr prior to behavioral assessment. The two lowest doses of triadimefon increased the frequency of locomotion and rearing, while the highest dose induced highly stereotyped behaviors, including backward locomotion, circling, and head weaving. Immediately after behavioral testing, the rats were sacrificed, and the striata and olfactory tubercles, terminal fields of the nigrostriatal and mesolimbic dopamine systems, respectively, were removed. Steady-state concentrations of the monoamines dopamine and serotonin and their metabolites were determined by HPLC-EC. In independent experiments, the direct effects of triadimefon on dopamine (D1 and D2) receptor binding and dopamine-sensitive adenylate cyclase activity were assessed in vitro using rat striata. Dopamine concentrations were increased in olfactory tubercles, but decreased in striatum. Concentrations of 5-hydroxyindoleacetic acid (the major metabolite of serotonin) were increased only in striatum, and only in animals treated with 200 mg/kg triadimefon. In vitro, triadimefon neither competed with D1 or D2 dopaminergic radioligands nor affected dopamine-stimulated adenylate cyclase activity. Together these behavioral and biochemical data lend support to the hypothesis that triadimefon may have actions similar to those produced by indirect-acting dopamine agonists.

Article Outline

• References

 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.